213 related articles for article (PubMed ID: 7944641)
1. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia.
Herrick AL; Heaney M; Hollis S; Jayson MI
Ann Rheum Dis; 1994 Aug; 53(8):540-2. PubMed ID: 7944641
[TBL] [Abstract][Full Text] [Related]
2. Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation.
Herrick AL; Oogarah PK; Freemont AJ; Marcuson R; Haeney M; Jayson MI
Ann Rheum Dis; 1994 May; 53(5):323-6. PubMed ID: 8017986
[TBL] [Abstract][Full Text] [Related]
3. Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.
Boin F; Franchini S; Colantuoni E; Rosen A; Wigley FM; Casciola-Rosen L
Arthritis Rheum; 2009 Aug; 60(8):2480-9. PubMed ID: 19644882
[TBL] [Abstract][Full Text] [Related]
4. Clinical setting of patients with systemic sclerosis by serum autoantibodies.
Picillo U; Migliaresi S; Marcialis MR; Ferruzzi AM; Tirri G
Clin Rheumatol; 1997 Jun; 16(4):378-83. PubMed ID: 9259252
[TBL] [Abstract][Full Text] [Related]
5. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma).
Hietarinta M; Lassila O; Hietaharju A
Scand J Rheumatol; 1994; 23(2):64-7. PubMed ID: 8165439
[TBL] [Abstract][Full Text] [Related]
6. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
7. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.
Spencer-Green G; Alter D; Welch HG
Am J Med; 1997 Sep; 103(3):242-8. PubMed ID: 9316557
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.
Wigley FM; Wise RA; Miller R; Needleman BW; Spence RJ
Arthritis Rheum; 1992 Jun; 35(6):688-93. PubMed ID: 1599523
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.
Picillo U; Migliaresi S; Marcialis MR; Ferruzzi AM; Tirri G
Autoimmunity; 1995; 20(1):1-7. PubMed ID: 7578856
[TBL] [Abstract][Full Text] [Related]
10. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies.
Hietarinta M; Tertti R; Lassila O
Clin Exp Rheumatol; 1993; 11(4):457-8. PubMed ID: 8403594
[No Abstract] [Full Text] [Related]
11. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
Behr J; König G; Meurer M; Krieg T
Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
14. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
15. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
[TBL] [Abstract][Full Text] [Related]
16. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis with sarcoidosis: case report and review of the published work.
Senda S; Igawa K; Nishioka M; Murota H; Katayama I
J Dermatol; 2014 May; 41(5):421-3. PubMed ID: 24617417
[TBL] [Abstract][Full Text] [Related]
18. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
19. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
